Abstract |
DNA vaccination against HER-2/neu is an effective way to induce an immune response able to oppose the spontaneous development of mammary tumours occurring in HER-2/neu transgenic mice. In this study, we have evaluated the potential of Imiquimod and the analogue S-27609 as adjuvants of DNA vaccination against HER-2/neu in transgenic mice. The association of a DNA vaccine encoding a portion of rat HER2/neu with either Imiquimod or S-27609 was found to delay the development of spontaneous mammary tumours and to reduce their incidence, in comparison with DNA vaccination alone. Almost 80 or 40% of tumour-free mice were found at the end of measurement time in mice vaccinated and supplemented with Imiquimod or S-27609, respectively. The antitumour preventive effect was associated with increased antibody and cell-mediated immune responsiveness against HER-2/neu. In mice vaccinated and supplemented with Imiquimod, a small but significant increase of rat p185neu-specific cytotoxicity and of IFN-gamma and IL-2-producing CD8T cells, together with a reduction of IL-4-producing CD4T cells, and a switch from an IgG1 towards a IgG2a phenotype of anti-p185neu antibodies, suggested a TH1 polarization of the immune response. The immunoregulatory efficacy of S-27609 was lower than that observed for Imiquimod. These data highlight the potential of Imiquimod, and, to a lower extent, of S-27609, as immunological adjuvants of therapeutic DNA vaccines.
|
Authors | A Smorlesi, F Papalini, F Orlando, A Donnini, F Re, M Provinciali |
Journal | Gene therapy
(Gene Ther)
Vol. 12
Issue 17
Pg. 1324-32
(Sep 2005)
ISSN: 0969-7128 [Print] England |
PMID | 15944732
(Publication Type: Journal Article)
|
Chemical References |
- 4-amino-alpha,alpha,2-trimethyl-1H-imidazo(4,5-c)quinoline-1-ethanol
- Adjuvants, Immunologic
- Aminoquinolines
- Cancer Vaccines
- Interleukin-2
- Vaccines, DNA
- Interleukin-10
- Interferon-gamma
- Imiquimod
|
Topics |
- Adjuvants, Immunologic
(administration & dosage)
- Adoptive Transfer
- Aminoquinolines
(administration & dosage)
- Animals
- Cancer Vaccines
(administration & dosage)
- Female
- Genes, erbB-2
- Genetic Therapy
(methods)
- Imiquimod
- Interferon-gamma
(immunology)
- Interleukin-10
(immunology)
- Interleukin-2
(immunology)
- Mammary Neoplasms, Experimental
(genetics, immunology, therapy)
- Mice
- Mice, Transgenic
- Models, Animal
- Vaccines, DNA
(administration & dosage)
|